window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-K89K5GY17G');

About DecodeHealth

This author has not yet filled in any details.
So far DecodeHealth has created 38 blog entries.
23 11, 2022

Decode Health’s Key Takeaways from HLTH 2022

2022-11-23T09:39:27-06:00

Last week’s fifth annual HLTH conference in Las Vegas was the biggest and boldest yet. The event was overflowing with interesting information and innovative ideas that push to define healthcare for the next decade. Many of the topics discussed tie directly to the work we do at Decode Health. Here are our team’s takeaways.

Decode Health’s Key Takeaways from HLTH 20222022-11-23T09:39:27-06:00
14 11, 2022

BD and Decode Health: Innovating to bring molecular tests to patients’ homes

2022-11-15T12:27:31-06:00

We’re excited to announce the BD and Decode Health strategic partnership that will accelerate innovation and advance precision medicine. Together, we’re working to advance at home collections for molecular biomarkers like RNA using a simple finger stick. Our work could unlock groundbreaking innovations for biomarker discovery and routine screening across multiple disciplines from oncology to autoimmune diseases and beyond. At-home testing can significantly improve efficiency and enhance diversity in clinical trials, speeding the development of potentially life-saving treatments.

BD and Decode Health: Innovating to bring molecular tests to patients’ homes2022-11-15T12:27:31-06:00
18 10, 2022

Decode Health Collaborates with Quest Diagnostics to Speed Biomarker Discovery for Drug and Diagnostics Development

2022-10-18T08:35:06-06:00

Decode Health, a healthcare AI company that enables a partner ecosystem to innovate and solve data challenges involving disease risk, today announced a new phase of its collaboration with Quest Diagnostics (NYSE: DGX), the world’s leading provider of diagnostic information services, to empower drug and diagnostics research and development in the growing fields of metabolic disease and autoimmune neurology.

Decode Health Collaborates with Quest Diagnostics to Speed Biomarker Discovery for Drug and Diagnostics Development2022-10-18T08:35:06-06:00
27 09, 2022

Decode Health Adds Board Chairman and Chief Medical Officer

2022-09-27T11:53:05-06:00

Decode Health, a rapidly growing healthcare AI company that enables a partner ecosystem to innovate and solve data challenges involving disease risk, announced today that two healthcare industry veterans will expand their current advisory roles within the company.

Decode Health Adds Board Chairman and Chief Medical Officer2022-09-27T11:53:05-06:00
15 06, 2022

Decode Health Earns DataRobot’s AI Innovator Award

2022-09-27T13:02:34-06:00

Decode Health was recently recognized with an AI Innovator Award at the DataRobot AIX 22 global virtual conference. DataRobot is a Boston-based AI cloud platform company that works with customers worldwide across industries and verticals, including almost 40% of Fortune 50 companies.

Decode Health Earns DataRobot’s AI Innovator Award2022-09-27T13:02:34-06:00
27 09, 2021

Influence of social determinants of health and county vaccination rates on machine learning models to predict COVID-19 case growth in Tennessee

2022-09-27T11:40:47-06:00

The SARS-CoV-2 (COVID-19) pandemic has exposed health disparities throughout the USA, particularly among racial and ethnic minorities. As a result, there is a need for data-driven approaches to pinpoint the unique constellation of clinical and social determinants of health (SDOH) risk factors that give rise to poor patient outcomes following infection in US communities.

Influence of social determinants of health and county vaccination rates on machine learning models to predict COVID-19 case growth in Tennessee2022-09-27T11:40:47-06:00
27 09, 2021

Predictive modeling of COVID-19 case growth highlights evolving racial and ethnic risk factors in Tennessee and Georgia

2022-09-27T11:43:18-06:00

The SARS-CoV-2 (COVID-19) pandemic has exposed the need to understand the risk drivers that contribute to uneven morbidity and mortality in US communities. Addressing the community-specific social determinants of health (SDOH) that correlate with spread of SARS-CoV-2 provides an opportunity for targeted public health intervention to promote greater resilience to viral respiratory infections.

Predictive modeling of COVID-19 case growth highlights evolving racial and ethnic risk factors in Tennessee and Georgia2022-09-27T11:43:18-06:00
27 05, 2021

Battling the Economic Toll of SARS-CoV-2 with Predictive Analytics

2022-09-27T13:06:44-06:00

According to an article in the Journal of the American Medical Association (JAMA), two Harvard economists estimate the cumulative financial costs of the COVID-19 pandemic at more than $16 trillion. To put this number into perspective, that’s approximately 90% of annual GDP of the United States or $200,000 for a family of four. This is a combination of lost income due to the COVID-induced recession and the economic effect of a shorter, less healthy life.

Battling the Economic Toll of SARS-CoV-2 with Predictive Analytics2022-09-27T13:06:44-06:00
Go to Top